×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EDSA – edesa biotech, inc. - common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EDSA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/4
05:28 pm
edsa
Edesa Biotech Announces Chief Financial Officer Transition [Canadian Business Journal (Canada)]
Medium
Report
Edesa Biotech Announces Chief Financial Officer Transition [Canadian Business Journal (Canada)]
4/4
05:13 pm
edsa
Edesa Biotech Announces Chief Financial Officer Transition [Yahoo! Finance]
Medium
Report
Edesa Biotech Announces Chief Financial Officer Transition [Yahoo! Finance]
4/4
04:15 pm
edsa
Edesa Biotech Announces Chief Financial Officer Transition
Low
Report
Edesa Biotech Announces Chief Financial Officer Transition
3/13
08:00 am
edsa
Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Medium
Report
Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
2/15
02:08 am
edsa
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results [Yahoo! Finance]
Medium
Report
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results [Yahoo! Finance]
2/14
05:28 pm
edsa
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results [Canadian Business Journal (Canada)]
Medium
Report
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results [Canadian Business Journal (Canada)]
2/14
04:15 pm
edsa
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
Medium
Report
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
2/13
11:09 am
edsa
Information Provided Pursuant to Early Warning Requirements with Respect to Par Nijhawan and Velan Capital [Yahoo! Finance]
Medium
Report
Information Provided Pursuant to Early Warning Requirements with Respect to Par Nijhawan and Velan Capital [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/4
04:25 pm
edsa
Form ARS Edesa Biotech, Inc. For: Sep 30
Medium
Report
Form ARS Edesa Biotech, Inc. For: Sep 30
4/4
04:24 pm
edsa
Form DEFA14A Edesa Biotech, Inc.
Medium
Report
Form DEFA14A Edesa Biotech, Inc.
4/4
04:22 pm
edsa
Form DEF 14A Edesa Biotech, Inc. For: May 28
Medium
Report
Form DEF 14A Edesa Biotech, Inc. For: May 28
4/4
04:20 pm
edsa
Form 8-K Edesa Biotech, Inc. For: Apr 03
Low
Report
Form 8-K Edesa Biotech, Inc. For: Apr 03
4/3
05:25 pm
edsa
Form 4 Edesa Biotech, Inc. For: Apr 01 Filed by: Nijhawan Pardeep
Low
Report
Form 4 Edesa Biotech, Inc. For: Apr 01 Filed by: Nijhawan Pardeep
3/12
06:02 am
edsa
Form EFFECT Edesa Biotech, Inc.
Medium
Report
Form EFFECT Edesa Biotech, Inc.
3/11
04:31 pm
edsa
Form 424B3 Edesa Biotech, Inc.
Medium
Report
Form 424B3 Edesa Biotech, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
9/5
Edesa Biotech Receives Approval to Initiate Clinical Study in Patients with Hemorrhoids
44.1%
3/19 Form 4 Edesa Biotech, Inc. For: Mar 17 Filed by: Nijhawan Pardeep 19.3%
9/10 Form SC 13D/A Edesa Biotech, Inc. Filed by: 10379085 Canada Inc. 13.6%
7/25 Edesa Biotech Completes Manufacturing for Upcoming Dermatitis Study 12.9%
2/14 Form 4 Edesa Biotech, Inc. For: Feb 12 Filed by: OAKES FRANK R. 11.0%
1/10 Form 4 Edesa Biotech, Inc. For: Jan 08 Filed by: Brooks Michael J 11.0%
7/10 Edesa Biotech Pushes Forward To Phase 2b Study For Lead Clinical Product [Seeking Alpha] 10.6%
8/29 Edesa Biotech to Present at H. C. Wainwright Global Investment Conference 10.6%
3/23 Form DEF 14A Edesa Biotech, Inc. For: May 13 8.1%
9/13 Form EFFECT Edesa Biotech, Inc. 7.6%
3/19 Form 4 Edesa Biotech, Inc. For: Mar 17 Filed by: Nijhawan Pardeep 19.3%
9/10 Form SC 13D/A Edesa Biotech, Inc. Filed by: 10379085 Canada Inc. 13.6%
7/25 Edesa Biotech Completes Manufacturing for Upcoming Dermatitis Study 12.9%
2/14 Form 4 Edesa Biotech, Inc. For: Feb 12 Filed by: OAKES FRANK R. 11.0%
1/10 Form 4 Edesa Biotech, Inc. For: Jan 08 Filed by: Brooks Michael J 11.0%
7/10 Edesa Biotech Pushes Forward To Phase 2b Study For Lead Clinical Product [Seeking Alpha] 10.6%
8/29 Edesa Biotech to Present at H. C. Wainwright Global Investment Conference 10.6%
3/23 Form DEF 14A Edesa Biotech, Inc. For: May 13 8.1%
9/13 Form EFFECT Edesa Biotech, Inc. 7.6%
TOP News Decliners
3/12
Edesa Biotech to Develop Novel Treatment for Vitiligo in Collaboration with the National Research Council of Canada
-19.6%
1/6 Edesa Biotech Announces $4.36 million Registered Direct Offering -19.5%
6/20 Form 8-K/A Edesa Biotech, Inc. For: Jun 07 -18.1%
6/11 Form 3 Edesa Biotech, Inc. For: Jun 07 Filed by: Nijhawan Pardeep -13.5%
3/9 Form EFFECT Edesa Biotech, Inc. -12.2%
1/10 Form 4 Edesa Biotech, Inc. For: Jan 08 Filed by: Pay Paul William -10.4%
8/14 Form 8-K Edesa Biotech, Inc. For: Aug 14 -9.2%
4/20 Edesa Biotech in-licenses two COVID-19 candidates; shares up 21% [Seeking Alpha] -8.9%
2/25 Form S-1 Edesa Biotech, Inc. -8.0%
3/30 Edesa Biotech (NASDAQ: EDSA) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a price target on the stock. -6.8%
1/6 Edesa Biotech Announces $4.36 million Registered Direct Offering -19.5%
6/20 Form 8-K/A Edesa Biotech, Inc. For: Jun 07 -18.1%
6/11 Form 3 Edesa Biotech, Inc. For: Jun 07 Filed by: Nijhawan Pardeep -13.5%
3/9 Form EFFECT Edesa Biotech, Inc. -12.2%
1/10 Form 4 Edesa Biotech, Inc. For: Jan 08 Filed by: Pay Paul William -10.4%
8/14 Form 8-K Edesa Biotech, Inc. For: Aug 14 -9.2%
4/20 Edesa Biotech in-licenses two COVID-19 candidates; shares up 21% [Seeking Alpha] -8.9%
2/25 Form S-1 Edesa Biotech, Inc. -8.0%
3/30 Edesa Biotech (NASDAQ: EDSA) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a price target on the stock. -6.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: